ExodusPoint Capital Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-262,134
| Closed | -$433K | – | 1539 |
|
2024
Q3 | $433K | Buy |
262,134
+155,412
| +146% | +$257K | ﹤0.01% | 1161 |
|
2024
Q2 | $237K | Buy |
106,722
+23,322
| +28% | +$51.8K | ﹤0.01% | 1234 |
|
2024
Q1 | $224K | Buy |
+83,400
| New | +$224K | ﹤0.01% | 1202 |
|
2023
Q2 | – | Sell |
-257,584
| Closed | -$410K | – | 1856 |
|
2023
Q1 | $410K | Sell |
257,584
-914,215
| -78% | -$1.46M | ﹤0.01% | 1294 |
|
2022
Q4 | $7.3M | Buy |
1,171,799
+806,848
| +221% | +$5.03M | 0.11% | 238 |
|
2022
Q3 | $2.45M | Buy |
364,951
+340,944
| +1,420% | +$2.28M | 0.03% | 675 |
|
2022
Q2 | $153K | Sell |
24,007
-18,499
| -44% | -$118K | ﹤0.01% | 1646 |
|
2022
Q1 | $197K | Buy |
42,506
+28,427
| +202% | +$132K | ﹤0.01% | 1860 |
|
2021
Q4 | $70K | Sell |
14,079
-49,381
| -78% | -$246K | ﹤0.01% | 1956 |
|
2021
Q3 | $765K | Buy |
+63,460
| New | +$765K | 0.01% | 1113 |
|